Notable Labs, Ltd. Stock price

Equities

NTBL

IL0012002452

Biotechnology & Medical Research

End-of-day quote Nasdaq 07:00:00 2024-03-25 pm EDT 5-day change 1st Jan Change
1.74 USD 0.00% Intraday chart for Notable Labs, Ltd. +8.75% -7.94%
Sales 2023 * - Sales 2024 * - Capitalization 16.23M
Net income 2023 * -14M Net income 2024 * -14M EV / Sales 2023 * -
Net cash position 2023 * - Net cash position 2024 * - EV / Sales 2024 * -
P/E ratio 2023 *
-1.11 x
P/E ratio 2024 *
-1.13 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 67.56%
More Fundamentals * Assessed data
Dynamic Chart
Notable Labs, Ltd. Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment CI
Top Premarket Gainers MT
JMP Securities Cuts Notable Labs' Price Target to $9 From $13, Keeps Market Outperform Rating MT
Notable Labs, Ltd. and CicloMed LLC Announces Initial Safety and Efficacy Data of Fosciclopirox and the Performance of PPMP CI
Transcript : Notable Labs, Inc., Vascular Biogenics Ltd. - M&A Call
Vascular Biogenics, Notable Labs Complete Merger MT
Vascular Biogenics Ltd.(NasdaqCM:VBLT) dropped from NASDAQ Composite Index CI
Notable Labs, Inc. completed the acquisition of Vascular Biogenics Ltd. from Aurum Ventures MKI Ltd. and others in reverse merger transaction. CI
Vascular Biogenics Ltd. Approves Board Appointments CI
Vascular Biogenics Ltd. has Changed its Name to Notable Labs, Ltd CI
Vascular Biogenics Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Vascular Biogenics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Vascular Biogenics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
An unknown buyer completed the acquisition of Manufacturing facility in Modiin, Israel and certain related assets from Vascular Biogenics Ltd.. CI
Aleph Farms Limited completed the acquisition of manufacturing facility in Israel from Vascular Biogenics Ltd.. CI
More news
1 week+8.75%
Current month+17.56%
1 month+22.11%
3 months-14.76%
Current year-7.94%
More quotes
1 week
1.64
Extreme 1.64
1.94
1 month
1.29
Extreme 1.29
1.94
Current year
1.01
Extreme 1.01
2.02
1 year
1.01
Extreme 1.01
5.27
3 years
1.01
Extreme 1.01
5.27
5 years
1.01
Extreme 1.01
5.27
10 years
1.01
Extreme 1.01
5.27
More quotes
Date Price Change Volume
24-03-27 1.8 +3.45% 46,546
24-03-26 1.74 0.00% 65,418
24-03-25 1.74 -8.90% 90,773
24-03-22 1.91 +11.70% 140,705
24-03-21 1.71 +6.87% 101,387

End-of-day quote Nasdaq, March 25, 2024

More quotes
Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The Company's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.8 USD
Average target price
9 USD
Spread / Average Target
+400.00%
Consensus
  1. Stock
  2. Equities
  3. Stock Notable Labs, Ltd. - Nasdaq